Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Targeted Therapy Against Colorectal Cancer (ATTACC) Screening Protocol

NCT01196130 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT01196130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01196130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Targeted Therapy Against Colorectal Cancer (ATTACC) Screening Protocol
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
December 9, 2022
Enrollment
1,275 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer